Author:
Boisselier Blandine,Marie Yannick,El Hallani Soufiane,Kaloshi Gentian,Iershov Anton,Kavsan Vadym,Psimaras Dimitri,Thillet Joëlle,Hoang-Xuan Khe,Delattre Jean-Yves,Sanson Marc
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference15 articles.
1. Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209
2. Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368
3. Shostak K, Labunskyy V, Dmitrenko V, Malisheva T, Shamayev M, Rozumenko V, Zozulya Y, Zehetner G, Kavsan V (2003) HC gp-39 gene is upregulated in glioblastomas. Cancer Lett 198:203–210. doi: 10.1016/S0304-3835(03)00310-0
4. Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO (2005) YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res 11:2258–2264. doi: 10.1158/1078-0432.CCR-04-1601
5. Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE (2005) Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci 96:183–190. doi: 10.1111/j.1349-7006.2005.00026.x
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献